RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Overview Fund Activity
Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

65 hedge funds and large institutions have $281M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
16
Increased
34
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$39.4M
2
TCM
2
Tekla Capital Management
Massachusetts
$7.42M
3
BlackRock
3
BlackRock
New York
$11.6M
4
Millennium Management
4
Millennium Management
New York
$3.71M
5
NI
5
Numeric Investors
Massachusetts
$2.48M

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$0
2
Jennison Associates
2
Jennison Associates
New York
$0
3
GTC
3
Ghost Tree Capital
New York
$1.59M
4
RSCM
4
Rock Springs Capital Management
Maryland
$11.2M
5
RG
5
Redmile Group
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
76
Meeder Asset Management
Ohio
– -$2K -79 Closed
MIM
77
Monashee Investment Management
Massachusetts
– -$322K – –
1 2 3
4